Current concepts and controversies in the management of early stage Hodgkin lymphoma.

about

Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.

P2860

Q37149757-F32491B8-8F15-4F7F-8220-D1A8369F8653

P2860

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q36061643

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

@ast

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

@en

type

Item

label

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

@ast

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

@en

prefLabel

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

@ast

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

@en

P1476

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

@en

P2093

Lauren S Maeda

http://www.w3.org/2001/XMLSchema#string

Mark Lee

http://www.w3.org/2001/XMLSchema#string

Ranjana H Advani

http://www.w3.org/2001/XMLSchema#string

P2860

Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer.

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.

Early-stage Hodgkin's lymphoma.

Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.

Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.

ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.

P304

962-971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2011.557455

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21463118

http://www.w3.org/2001/XMLSchema#string

P932

4570567

http://www.w3.org/2001/XMLSchema#string

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

about

P2860

P2860

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932